Literature DB >> 28930543

EEG and ERP biomarkers of Alzheimer's disease: a critical review.

Andras Horvath1, Anna Szucs2, Gabor Csukly3, Anna Sakovics2, Gabor Stefanics4, Anita Kamondi2.   

Abstract

Here we critically review studies that used electroencephalography (EEG) or event-related potential (ERP) indices as a biomarker of Alzheimer's disease. In the first part we overview studies that relied on visual inspection of EEG traces and spectral characteristics of EEG. Second, we survey analysis methods motivated by dynamical systems theory (DST) as well as more recent network connectivity approaches. In the third part we review studies of sleep.  Next, we compare the utility of early and late ERP components in dementia research. In the section on mismatch negativity (MMN) studies we summarize their results and limitations and outline the emerging field of computational neurology. In the following we overview the use of EEG in the differential diagnosis of the most common neurocognitive disorders. Finally, we provide a summary of the state of the field and conclude that several promising EEG/ERP indices of synaptic neurotransmission are worth considering as potential biomarkers. Furthermore, we highlight some practical issues and discuss future challenges as well.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28930543     DOI: 10.2741/4587

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  35 in total

Review 1.  Neurophysiological markers of network dysfunction in neurodegenerative diseases.

Authors:  Roisin McMackin; Peter Bede; Niall Pender; Orla Hardiman; Bahman Nasseroleslami
Journal:  Neuroimage Clin       Date:  2019-02-02       Impact factor: 4.881

Review 2.  A Novel Explainability Approach for Technology-Driven Translational Research on Brain Aging.

Authors:  Adam Turnbull; Robert M Kaplan; Ehsan Adeli; Feng V Lin
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 3.  Clinical applications of EEG as an excellent tool for event related potentials in psychiatric and neurotic disorders.

Authors:  Charushila Jadhav; Priti Kamble; Shafique Mundewadi; Nitesh Jaiswal; Snehalata Mali; Surbhi Ranga; Tarun Kumar Suvvari; Atul Rukadikar
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-04-15

4.  BRAINCODE for Cognitive Impairment Diagnosis in Older Adults: Designing a Case-Control Pilot Study.

Authors:  Pedro Rocha; Paulina Clara Dagnino; Ronan O'Sullivan; Aureli Soria-Frisch; Constança Paúl
Journal:  Int J Environ Res Public Health       Date:  2022-05-09       Impact factor: 4.614

5.  Multimodal measurement approach to identify individuals with mild cognitive impairment: study protocol for a cross-sectional trial.

Authors:  Bernhard Grässler; Fabian Herold; Milos Dordevic; Tariq Ali Gujar; Sabine Darius; Irina Böckelmann; Notger G Müller; Anita Hökelmann
Journal:  BMJ Open       Date:  2021-05-25       Impact factor: 2.692

Review 6.  Therapy for Alzheimer's disease: Missing targets and functional markers?

Authors:  Milan Stoiljkovic; Tamas L Horvath; Mihály Hajós
Journal:  Ageing Res Rev       Date:  2021-03-09       Impact factor: 11.788

7.  Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects.

Authors:  Wei Yin; Fahimeh Mamashli; Derek L Buhl; Polyna Khudyakov; Dmitri Volfson; Ferenc Martenyi; Hakop Gevorkyan; Laura Rosen; Arthur A Simen
Journal:  Br J Clin Pharmacol       Date:  2021-07-31       Impact factor: 3.716

8.  Myoclonus induced by amoxicillin-clavulanic acid.

Authors:  Alejandro Viloria-Alebesque; Marina Povar-Echeverría; María Jesús Bruscas-Alijarde; Anyuli Gracia-Gutiérrez; Leticia Royo-Trallero; Patricia Al-Cheikh-Felices
Journal:  Epilepsy Behav Rep       Date:  2020-04-30

9.  Feasibility of Repeated Assessment of Cognitive Function in Older Adults Using a Wireless, Mobile, Dry-EEG Headset and Tablet-Based Games.

Authors:  Esther C McWilliams; Florentine M Barbey; John F Dyer; Md Nurul Islam; Bernadette McGuinness; Brian Murphy; Hugh Nolan; Peter Passmore; Laura M Rueda-Delgado; Alison R Buick
Journal:  Front Psychiatry       Date:  2021-06-25       Impact factor: 4.157

10.  Dietary Melatonin Therapy Alleviates the Lamina Cribrosa Damages in Patients with Mild Cognitive Impairments: A Double-Blinded, Randomized Controlled Study.

Authors:  Lei Xu; Haixiang Yu; Hongbin Sun; Bang Hu; Yi Geng
Journal:  Med Sci Monit       Date:  2020-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.